Michele focuses on private equity transactions within the health care industry. She serves as general and special counsel to private equity firms and other investors looking to make investments in health care. Michele also helps companies address evolving concepts and capitalize on opportunities emerging from the accelerating convergence of health care and technology.

Michele focuses her practice almost exclusively on representing for-profit health care entities in private equity and other corporate transactions. Currently, she represents health care-focused middle-market private equity firms through their initial acquisitions and various add-ons of portfolio companies.

She advises health care providers on joint ventures, mergers and acquisitions, and contractual arrangements. As a former in-house counsel at a hospital, Michele’s uniquely holistic perspective helps her guide health care clients juggling day-to-day operational issues and new business ventures.

In her work with middle-market private equity firms, Michele is routinely helping clients with their investments in health care management companies. She understands the health care laws and regulations that place restrictions on certain private equity investments.

With the Accountable Care movement in full effect, it’s more important than ever for providers to participate in alternative delivery systems that drive efficiencies and contain costs. Michele advises her clients from the initial analysis of their existing models through the formation and implementation of new operational models, such as value-based contracting, ACOs, bundled payments, and medical homes.

By identifying transaction structures most likely to attract attention from state and federal regulatory agencies, Michele helps her clients address the underlying licensure, fraud and abuse, and other issues that often stand in the way in New York. Local and out-of-state clients involved in health care M&A turn to her to navigate the New York regulatory environment and minimize the risk of regulatory challenges.